1418 A PHASE-2, RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL OF ARAMCHOL FOR THE TREATMENT OF NON ALCOHOLIC FATTY LIVER DISEASE (NAFLD)